STRUCTURAL GENOMICS CENTERS FOR INFECTIOUS DISEASES - SARS-CoV-2 RESEARCH
Document text
Principal Investigator: PETER MYLER Organization: SEATTLE CHILDREN'S HOSPITAL Fiscal Year: 2020 Award: $580,155 Funding agency: National Institute of Allergy and Infectious Diseases The goal of the Structural Genomics Centers for Infectious Diseases is to apply state-of-the-art, high-throughput structural biology technologies to experimentally characterize the three-dimensional atomic structure of targeted proteins on the NIAID Category A-C priority pathogens list and organisms causing emerging and re-emerging infectious diseases. This program also supports research projects that utilize the 3D structure information and experimental approaches to better characterize the molecular functional role of protein targets. The primary focus of the Center is pathogen proteins that are expected to have an important biological role and a potential impact on biomedical research. Terms: <2019 novel coronavirus><2019-nCoV><3-D><3-D structure><3-Dimensional><3-dimensional structure><3D><3D structure><Basic Research><Basic Science><Biological><Biomedical Research><COVID-19><COVID19><Categories><Emerging Communicable Diseases><Emerging Infectious Diseases><Genomic Centers for Infectious Diseases><Goals><Molecular><NIAID><National Institute of Allergy and Infectious Disease><Organism><Proteins><R-Series Research Projects><R01 Mechanism><R01 Program><Research Grants><Research Project Grants><Research Projects><Research Support><Role><SARS-CoV-2><SARS-CoV2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related coronavirus 2><Severe acute respiratory syndrome coronavirus 2><Structure><Technology><Wuhan coronavirus><corona virus disease 2019><coronavirus disease 2019><living system><pathogen><priority pathogen><programs><social role><structural biology><structural genomics><three dimensional><three dimensional structure>